BIOMAT Database Logo BIOMAT Database Logo

One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. 2000

S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia, Canada.

BACKGROUND Esomeprazole is the first proton pump inhibitor to be developed as an optical isomer for the treatment of acid-related diseases. METHODS Four hundred and forty eight duodenal ulcer patients with Helicobacter pylori infection, confirmed by 13C-urea breath test (UBT), and no current ulcer, were randomised to double-blind treatment with esomeprazole 20 mg twice daily (b.d.) (n=224) or omeprazole 20 mg b.d. (n=224), in combination with amoxicillin 1 g b.d. and clarithromycin 500 mg b.d. for 1 week (EAC and OAC, respectively). A negative UBT at both 4 and 8 weeks after completing therapy indicated successful H. pylori eradication. RESULTS Intention-to-treat (ITT) analysis comprised 400 patients (EAC, n=204; OAC, n=196) and per protocol (PP) analysis 377 patients (EAC, n=192; OAC, n=185). Eradication rates (95% confidence intervals) for ITT and PP populations were: EAC, 90% (85-94%) and 91% (86-94%); OAC, 88% (82-92%) and 91% (86-95%). Between-group differences in eradication rates were not statistically significant. Both regimens were well tolerated, with an adverse event profile and frequency typical of proton pump inhibitor plus antibiotic combination therapy. CONCLUSIONS Esomeprazole-based triple therapy for 1 week is highly effective in eradicating H. pylori infection in duodenal ulcer disease, offers comparable efficacy to omeprazole-based therapy, and is well tolerated.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.
June 2003, Alimentary pharmacology & therapeutics,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
One week regimen of esomeprazole based triple therapy is sufficient for duodenal ulcer healing and Helicobacter pylori eradication in patients with duodenal ulcer disease.
August 2002, European journal of gastroenterology & hepatology,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
One week triple therapy for Helicobacter pylori associated duodenal ulcer disease.
December 1999, Singapore medical journal,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.
December 2001, European journal of gastroenterology & hepatology,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
May 1993, Medizinische Klinik (Munich, Germany : 1983),
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
December 1995, Leber, Magen, Darm,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
One week of esomeprazole triple therapy vs 1 week of omeprazole triple therapy plus 3 weeks of omeprazole for duodenal ulcer healding in Helicobacter pylori-positive patients.
June 2007, Digestive diseases and sciences,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
Helicobacter pylori clearance and eradication with triple therapy in duodenal ulcer patients.
January 1995, JPMA. The Journal of the Pakistan Medical Association,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
Views on esomeprazole-based triple therapy to treat duodenal ulcer disease and Helicobacter pylori infection.
June 2002, European journal of gastroenterology & hepatology,
S Veldhuyzen Van Zanten, and K Lauritsen, and J C Delchier, and J Labenz, and C M De Argila, and T Lind, and H C Treichel, and A Stubberöd, and A Cockeram, and G Hasselgren, and L Göthe, and M Wrangstadh, and P Sinclair
One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication.
August 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Copied contents to your clipboard!